2014
DOI: 10.1002/gps.4187
|View full text |Cite
|
Sign up to set email alerts
|

Older adults recently started on psychotropic medication: where are the symptoms?

Abstract: In this sample of older adults on new psychotropic medication with minimal psychiatric symptoms, there are few patient characteristics that distinguish those on antidepressant versus anxiolytic monotherapy or those on monotherapy versus combination therapy. While quality of care in late-life mental health has focused on improving detection and treatment, there should be further attention to low-symptom patients potentially receiving inappropriate pharmacotherapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 39 publications
0
4
0
Order By: Relevance
“…In addition to treatment of mental health problems, such as depression, anxiety, and insomnia, psychotopic drugs are also prescribed to older patients for behavioural and psychological symptoms of dementia (BPSD) (Gustafsson et al, 2013). Thus, psychotropic drugs are used extensively among older people (Johnell and Fastbom 2012) and there is a risk that these drugs are used long-term and off-label (Maust et al, 2015a).…”
Section: Introductionmentioning
confidence: 99%
“…In addition to treatment of mental health problems, such as depression, anxiety, and insomnia, psychotopic drugs are also prescribed to older patients for behavioural and psychological symptoms of dementia (BPSD) (Gustafsson et al, 2013). Thus, psychotropic drugs are used extensively among older people (Johnell and Fastbom 2012) and there is a risk that these drugs are used long-term and off-label (Maust et al, 2015a).…”
Section: Introductionmentioning
confidence: 99%
“…Although the use of evidence‐based psychotherapy options is preferred in older adults, it is more common for clinicians to select medication strategies with this population. In fact, it has been common practice for clinicians to initiate pharmacotherapy in the near‐absence of symptoms on clinical assessment (Maust, Chen, Benson, Mavandadi, Streim, DiFilippo, Snedden, & Oslin, ). Clinically inappropriate medications continue to be prescribed and preferred by many clinicians over nonpharmacological strategies despite continued evidence demonstrating poor outcomes in older adults (AGS, ).…”
Section: Resultsmentioning
confidence: 99%
“…Not only are larger numbers of psychotropics, particularly benzodiazepines, being prescribed to older adults, Maust, Oslin, and Marcus () noted that often these patients do not have a psychiatric diagnosis. In the case of depression and anxiety, benzodiazepines were often initiated with few symptoms of the disease (Maust, Mavandadi, et al., ; Maust, Chen, et al., ). Of concern, this lends to the possibility of inappropriate uses of benzodiazepine medications in the elderly, placing them at increased risk for memory impairment, hypersomnolence, falls, fractures, motor vehicle accidents, and addiction.…”
Section: Introductionmentioning
confidence: 99%
“…SF–36, SF–12, and SF–8 have been amply used in elderly populations (i.e., Gregorio et al, 2014; Maust et al, 2015; Naseer & Fagerström, 2015; Neubauer et al, 2012; Orive et al, 2015). But, whereas there is plentiful evidence on SF–36 and SF–12’s psychometric properties, research on SF–8 behavior is scarce, and it only includes four studies: the one by the developers of the reduced version (Ware et al, 2001); one that took place in Uganda (Roberts, Browne, Ocaka, Oyok, & Sondorp, 2008); another one carried out in Japan (Tokuda et al, 2009), and a fourth one developed in Spain (Vallès et al, 2010).…”
mentioning
confidence: 99%